← FDA Drug Approvals (Drugs@FDA)
DAPTOMYCIN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HANGZHOU ZHONGMEI · Approved 2021-11-26
Drug application
- FDA Application #
ANDA215215- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DAPTOMYCIN
- Generic name
- Daptomycin
- Active ingredients
- DAPTOMYCIN
- Dosage form
- POWDER
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- HANGZHOU ZHONGMEI
- First approval
- 2021-11-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown